COMP <GO>
G vs EXPO // 10Y YIELD & FRED MACRO BETA
Genpact Limited (NYSE) VS. Exponent Inc. (NASDAQ) • 15-METRIC TALLY: G 7
— EXPO 6
▲ 10Y YIELD & FRED MACRO BETA LEADER: EXPO
LAST: $40.52 (+2.27%) • MKT CAP: $6.78B
macro-sensitivity
0.89
LAST: $86.58 (+7.87%) • MKT CAP: $4.12B
macro-sensitivity
0.94
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (G VS. EXPO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | G | EXPO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.70% | 28.60% | -7.90 | EXPO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 8.4x | 28.7x | -20.30 | G | /valuation <GO> |
| Free Cash Flow Yield | 11.27% | 3.29% | +7.98 | G | /fcf-yield <GO> |
| Operating Margin | 14.80% | 20.60% | -5.80 | EXPO | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 18.20% | -7.30 | EXPO | /net-margins <GO> |
| Revenue Growth (YoY) | 6.60% | 4.20% | +2.40 | G | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.81% | 1.65% | +0.16 | G | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.03 | 8.62 | -5.59 | EXPO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | G | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.1 | 81.1 | -16.00 | EXPO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.89 | 0.94 | -0.05 | EXPO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.0x | 32.6x | -21.60 | G | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.78B | $4.12B | $2.66B | G | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | G REV | EXPO REV | G GROSS % | EXPO GROSS % | G FCF | EXPO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.08B | $582.0M | 36.0% | — | $734.7M | $122.3M |
| FY 2024 | $4.77B | $558.5M | 35.5% | — | $532.7M | $137.6M |
| FY 2023 | $4.48B | $536.8M | — | — | $289.4M | $103.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
G // BETA 0.89
EXPO // BETA 0.94